MicroRNA as Biomarkers and Diagnostics

Journal of Cellular Physiology

Volumn 231, Issue 1, 2016, Pages 25-30

  Wang, Jin ^a   Chen, Jinyun ^a   Sen, Subrata ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; TUMOR MARKER;

3' UNTRANSLATED REGION; ANGIOGENESIS; APOPTOSIS; BASE PAIRING; CARDIOVASCULAR DISEASE; CELL ADHESION; CELL DIFFERENTIATION; CELL METABOLISM; CELL PROLIFERATION; DIABETES MELLITUS; GENE EXPRESSION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; METABOLIC DISORDER; MOLECULAR DIAGNOSIS; MUSCLE DISEASE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; VIRUS INFECTION; ANIMAL; AUTOIMMUNE DISEASES; CARDIOVASCULAR DISEASES; GENETIC PREDISPOSITION; GENETICS; NEOPLASMS;

ANIMALS; AUTOIMMUNE DISEASES; BIOMARKERS, TUMOR; CARDIOVASCULAR DISEASES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICRORNAS; NEOPLASMS;

EID: 84942337267     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25056     Document Type: Review

References (119)

1. Abelson JF, Kwan KY, O'Roak BJ, Baek DY, Stillman AA, Morgan TM, Mathews CA, Pauls DL, Rasin MR, Gunel M, Davis NR, Ercan-Sencicek AG, Guez DH, Spertus JA, Leckman JF, Dure LSt, Kurlan R, Singer HS, Gilbert DL, Farhi A, Louvi A, Lifton RP, Sestan N, State MW. 2005. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 310:317-320.
2. Ai J, Zhang R, Li Y, Pu JL, Lu YJ, Jiao JD, Li K, Yu B, Li ZQ, Wang RR, Wang LH, Li Q, Wang N, Shan HL, Li ZY, Yang BF. 2010. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Bioph Res Co 391:73-77.
3. Albinsson S, Suarez Y, Skoura A, Offermanns S, Miano JM, Sessa WC. 2010. MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function. Arterioscler Thromb Vasc Biol 30:1118-1126.
4. Ambros V 2004. The functions of animal microRNAs. Nature 431:350-355.
5. Anadol E, Schierwagen R, Elfimova N, Tack K, Schwarze-Zander C, Eischeid H, Noetel A, Boesecke C, Jansen C, Dold L, Wasmuth JC, Strassburg CP, Spengler U, Rockstroh JK, Odenthal M, Trebicka J. 2015. Circulating microRNAs as a marker for liver injury in human immunodeficiency virus patients. Hepatology 61:46-55.
6. Barshack I, Lithwick-Yanai G, Afek A, Rosenblatt K, Tabibian-Keissar H, Zepeniuk M, Cohen L, Dan H, Zion O, Strenov Y, Polak-Charcon S, Perelman M. 2010. MicroRNA expression differentiates between primary lung tumors and metastases to the lung. Pathol Res Pract 206:578-584.
7. Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116:281-297.
8. Bavamian S, Mellios N, Lalonde J, Fass DM, Wang J, Sheridan SD, Madison JM, Zhou F, Rueckert EH, Barker D, Perlis RH, Sur M, Haggarty SJ. 2015. Dysregulation of miR-34a links neuronal development to genetic risk factors for bipolar disorder. Molecular psychiatry 20:573-584.
9. Ben-Dov IZ, Tan YC, Morozov P, Wilson PD, Rennert H, Blumenfeld JD, Tuschl T. 2014. Urine microRNA as potential biomarkers of autosomal dominant polycystic kidney disease progression: Description of miRNA profiles at baseline. PloS ONE 9:e86856.
10. Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, Li MZ, Mills AA, Elledge SJ, Anderson KV, Hannon GJ. 2003. Dicer is essential for mouse development. Nat Genet 35:215-217.
11. Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, Dumitru CD, Shimizu M, Cimmino A, Zupo S, Dono M, Dell'Aquila ML, Alder H, Rassenti L, Kipps TJ, Bullrich F, Negrini M, Croce CM. 2004a. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 101:11755-11760.
12. Calin GA, Sevignani C, Dan Dumitru C, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM. 2004b. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101:2999-3004.
13. Cao X, Yeo G, Muotri AR, Kuwabara T, Gage FH. 2006. Noncoding RNAs in the mammalian central nervous system. Annu Rev Neurosci 29:77-103.
14. Chen AK, Sengupta P, Waki K, Van Engelenburg SB, Ochiya T, Ablan SD, Freed EO, Lippincott-Schwartz J. 2014a. MicroRNA binding to the HIV-1 Gag protein inhibits Gag assembly and virus production. Proc Natl Acad Sci USA 111:E2676-E2683.
15. Chen H, Lan HY, Roukos DH, Cho WC. 2014b. Application of microRNAs in diabetes mellitus. J Endocrinol 222:R1.
16. Chen WL, Lin JW, Huang HJ, Wang SM, Su MT, Lee-Chen GJ, Chen CM, Hsieh-Li HM. 2008a. SCA8 mRNA expression suggests an antisense regulation of KLHL1 and correlates to SCA8 pathology. Brain Res 1233:176-184.
17. Chen X, Ba Y, Ma LJ, Cai X, Yin Y, Wang KH, Guo JG, Zhang YJ, Chen JN, Guo X, Li QB, Li XY, Wang WJ, Zhang Y, Wang J, Jiang XY, Xiang Y, Xu C, Zheng PP, Zhang JB, Li RQ, Zhang HJ, Shang XB, Gong T, Ning G, Wang J, Zen K, Zhang JF, Zhang CY. 2008b. Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18:997-1006.
18. Chen CF, Ridzon DA, Broomer AJ, Zhou ZH, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ. 2005. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33:e179.
19. Chen Z, Xu L, Ye X, Shen S, Li Z, Niu X, Lu S. 2013. Polymorphisms of microRNA sequences or binding sites and lung cancer: A meta-analysis and systematic review. PloS one 8:e61008.
20. Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L, Wagner DR, Staessen JA, Heymans S, Schroen B. 2010. Circulating microRNA-208b and microRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Gene 3:499-506.
21. Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA. 2011. MicroRNAs in body fluids-the mix of hormones and biomarkers. Nat Rev Clin Oncol 8:467-477.
22. da Silva AMG, Silbiger VN. 2014. MiRNAs as biomarkers of atrial fibrillation. Biomarkers 19:631-636.
23. Edbauer D, Neilson JR, Foster KA, Wang CF, Seeburg DP, Batterton MN, Tada T, Dolan BM, Sharp PA, Sheng M. 2010. Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron 65:373-384.
24. Eisenberg I, Eran A, Nishino I, Moggio M, Lamperti C, Amato AA, Lidov HG, Kang PB, North KN, Mitrani-Rosenbaum S, Flanigan KM, Neely LA, Whitney D, Beggs AH, Kohane IS, Kunkel LM. 2007. Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci USA 104:17016-17021.
25. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, Watts L, Booten SL, Graham M, McKay R, Subramaniam A, Propp S, Lollo BA, Freier S, Bennett CF, Bhanot S, Monia BP. 2006. MiR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3:87-98.
26. Esquela-Kerscher A, Slack FJ. 2006. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6:259-269.
27. Esteller M. 2011. Non-coding RNAs in human disease. Nat Rev Genet 12:861-874.
28. Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E, Liu S, Alder H, Costinean S, Fernandez-Cymering C, Volinia S, Guler G, Morrison CD, Chan KK, Marcucci G, Calin GA, Huebner K, Croce CM. 2007. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA 104:15805-15810.
29. Femminella GD, Ferrara N, Rengo G. 2015. The emerging role of microRNAs in Alzheimer's disease. Front Physiol 6:40.
30. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Roxe T, Muller-Ardogan M, Bonauer A, Zeiher AM, Dimmeler S. 2010. Circulating microRNAs in patients with coronary artery disease. Circ Res 107:677-U257.
31. Fridman E, Dotan Z, Barshack I, Ben David M, Dov A, Tabak S, Zion O, Benjamin S, Benjamin H, Kuker H, Avivi C, Rosenblatt K, Polak-Charcon S, Ramon J, Rosenfeld N, Spector Y. 2010. Accurate molecular classification of renal tumors using microRNA expression. J Mol Diagn 12:687-696.
32. Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R. 2005. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 123:631-640.
33. Hatley ME, Patrick DM, Garcia MR, Richardson JA, Bassel-Duby R, van Rooij E, Olson EN. 2010. Modulation of K-Ras-Dependent lung tumorigenesis by microRNA-21. Cancer cell 18:282-293.
34. Haybaeck J, Zeller N, Heikenwalder M. 2011. The parallel universe: MicroRNAs and their role in chronic hepatitis, liver tissue damage and hepatocarcinogenesis. Swiss Med Wkly 141 w13287.
35. Hebert SS, De Strooper B. 2009. Alterations of the microRNA network cause neurodegenerative disease. Trends Neurosci 32:199-206.
36. Heneghan HM, Miller N, Kelly R, Newell J, Kerin MJ. 2010. Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease. Oncologist 15:673-682.
37. Hollins SL, Goldie BJ, Carroll AP, Mason EA, Walker FR, Eyles DW, Cairns MJ. 2014. Ontogeny of small RNA in the regulation of mammalian brain development. BMC genomics 15:777.
38. Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, Camargo A, Gupta S, Moore J, Wrobel MJ, Lerner J, Reich M, Chan JA, Glickman JN, Ikeda K, Hashimoto M, Watanabe G, Daidone MG, Roayaie S, Schwartz M, Thung S, Salvesen HB, Gabriel S, Mazzaferro V, Bruix J, Friedman SL, Kumada H, Llovet JM, Golub TR. 2008. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. The N Engl J Med 359:1995-2004.
39. Huang JT, Wang J, Srivastava V, Sen S, Liu SM. 2014. MicroRNA machinery genes as novel biomarkers for cancer. Front Oncol 4:113.
40. Huang ZH, Huang D, Ni SJA, Peng ZL, Sheng WQ, Du X. 2010. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 127:118-126.
41. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM. 2005. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65:7065-7070.
42. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, Calin GA, Menard S, Croce CM. 2007. MicroRNA signatures in human ovarian cancer. Cancer Res 67:8699-8707.
43. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. 2005. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309:1577-1581.
44. Kloosterman WP, Wienholds E, de Bruijn E, Kauppinen S, Plasterk RHA. 2006. In situ detection of miRNAs in animal embryos using LNA-modified oligonucteotide probes. Nat Methods 3:27-29.
45. Kutok JL, Wang F. 2006. Spectrum of Epstein-Barr virus-associated diseases. Ann Rev Pathol 1:375-404.
46. Kuwabara Y, Ono K, Horie T, Nishi H, Nagao K, Kinoshita M, Watanabe S, Baba O, Kojima Y, Shizuta S, Imai M, Tamura T, Kita T, Kimura T. 2011. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ Cardiovasc Gene 4:U287-U446.
47. Lawrie CH, Soneji S, Marafioti T, Cooper CDO, Palazzo S, Paterson JC, Cattan H, Enver T, Mager R, Boultwood J, Wainscoat JS, Hatton CSR. 2007. MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer 121:1156-1161.
48. Lecellier CH, Dunoyer P, Arar K, Lehmann-Che J, Eyquem S, Himber C, Saib A, Voinnet O. 2005. A cellular microRNA mediates antiviral defense in human cells. Science 308:557-560.
49. Lee RC, Feinbaum RL, Ambros V. 1993. The C-elegans heterochronic gene lin-4 encodes small Rnas with antisense complementarity to lin-14. Cell 75:843-854.
50. Lin J, Li J, Huang B, Liu J, Chen X, Chen XM, Xu YM, Huang LF, Wang XZ. 2015. Exosomes: Novel biomarkers for clinical diagnosis. ScientificWorldJournal 2015:657086.
51. Ling SC, Albuquerque CP, Han JS, Lagier-Tourenne C, Tokunaga S, Zhou H, Cleveland DW. 2010. ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Proc Natl Acad Sci USA 107:13318-13323.
52. Liu R, Zhang CN, Hu ZB, Li G, Wang C, Yang CH, Huang DZ, Chen X, Zhang HY, Zhuang R, Deng T, Liu H, Yin JJ, Wang SF, Zen K, Ba Y, Zhang CY. 2011. A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer 47:784-791.
53. Liu Y, Gao G, Yang C, Zhou K, Shen B, Liang H, Jiang X. 2014. The role of circulating microRNA-126 (miR-126): A novel biomarker for screening prediabetes and newly diagnosed type 2 diabetes mellitus. Int J Mol Sci 15:10567-10577.
54. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR. 2005. MicroRNA expression profiles classify human cancers. Nature 435:834-838.
55. Luna JM, Scheel TK, Danino T, Shaw KS, Mele A, Fak JJ, Nishiuchi E, Takacs CN, Catanese MT, de Jong YP, Jacobson IM, Rice CM, Darnell RB. 2015. Hepatitis C virus RNA functionally sequesters miR-122. Cell 160:1099-1110.
56. Lynn FC 2009. Meta-regulation: MicroRNA regulation of glucose and lipid metabolism. Trends Endocrinol Metab 20:452-459.
57. Margis R, Margis R, Rieder CR. 2011. Identification of blood microRNAs associated to Parkinsonis disease. J Biotechnol 152:96-101.
58. Matkovich SJ, Van Booven DJ, Youker KA, Torre-Amione G, Diwan A, Eschenbacher WH, Dorn LE, Watson MA, Margulies KB, Dorn GW. 2009. Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation 119:1263-U1277.
59. Mehler MF, Mattick JS. 2007. Noncoding RNAs and RNA editing in brain development, functional diversification, and neurological disease. Physiol Rev 87:799-823.
60. Meng F, Wehlbe-Janek H, Henson R, Ghoshal K, Jacob ST, Patel T. 2007. Microrna-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular carcinoma. Gastroenterology 132:A730.
61. Meyer SU, Pfaffl MW, Ulbrich SE. 2010. Normalization strategies for microRNA profiling experiments: A 'normal' way to a hidden layer of complexity? Biotechnol Lett 32:1777-1788.
62. Michael A, Bajracharya SD, Yuen PST, Zhou H, Star RA, Illei GG, Alevizos I. 2010. Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis 16:34-38.
63. Misso G, Di Martino MT, De Rosa G, Farooqi AA, Lombardi A, Campani V, Zarone MR, Gulla A, Tagliaferri P, Tassone P, Caraglia M. 2014. Mir-34: A New Weapon Against Cancer? Mol Ther-Nucl Acids 3 e194.
64. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M. 2008. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105:10513-10518.
65. Murakami Y, Aly HH, Tajima A, Inoue I, Shimotohno K. 2009. Regulation of the hepatitis C virus genome replication by miR-199a. J Hepatol 50:453-460.
66. Nielsen LB, Wang C, Sorensen K, Bang-Berthelsen CH, Hansen L, Andersen ML, Hougaard P, Juul A, Zhang CY, Pociot F, Mortensen HB. 2012. Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: Evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression. Exp Diabetes Res 2012:896362.
67. Pekarsky Y, Croce CM. 2010. Is miR-29 an oncogene or tumor suppressor in CLL? Oncotarget 1:224-227.
68. Perkins DO, Jeffries CD, Jarskog LF, Thomson JM, Woods K, Newman MA, Parker JS, Jin J, Hammond SM. 2007. MicroRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol 8:R27.
69. Philippen LE, Dirkx E, da Costa-Martins PA, De Windt LJ. 2015. Non-coding RNA in control of gene regulatory programs in cardiac development and disease. J Mol Cell Cardiol pii:S0022-2828(15)00100-5.
70. Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TLJ, Visakorpi T. 2007. MicroRNA expression profiling in prostate cancer. Cancer Res 67:6130-6135.
71. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P, Stoffel M. 2004. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432:226-230.
72. Qi J, Wang J, Katayama H, Sen S, Liu SM. 2013. Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma. Neoplasma 60:135-142.
73. Qi JH, Wang J, Chen JY, Shen F, Huang JT, Sen S, Zhou X, Liu SM. 2014. High-resolution melting analysis reveals genetic polymorphisms in MicroRNAs confer hepatocellular carcinoma risk in Chinese patients. Bmc Cancer 14 643.
74. Qiu L, Zhang W, Tan EK, Zeng L. 2014. Deciphering the function and regulation of microRNAs in Alzheimer's disease and Parkinson's disease. ACS Chem Neurosci 5:884-894.
75. Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD, Kloecker GH. 2009. Exosomal microRNA: A diagnostic marker for lung cancer. Clin Lung Cancer 10:42-46.
76. Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE. 2009. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 112:55-59.
77. Roth C, Kasimir-Bauer S, Pantel K, Schwarzenbach H. 2011. Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer. Mol Oncol 5:281-291.
78. Sato F, Tsuchiya S, Terasawa K, Tsujimoto G. 2009. Intra-platform repeatability and inter-platform comparability of microRNA microarray technology. PloS ONE 4:e5540.
79. Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M. 2007. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 100:416-424.
80. Sayed D, Rane S, Lypowy J, He MZ, Chen IY, Vashistha H, Yan L, Malhotra A, Vatner D, Abdellatif M. 2008. MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Mol Biol Cell 19:3272-3282.
81. Scaria V, Hariharan M, Maiti S, Pillai B, Brahmachari SK. 2006. Host-virus interaction: A new role for microRNAs. Retrovirology 3:68.
82. Schratt GM, Tuebing F, Nigh EA, Kane CG, Sabatini ME, Kiebler M, Greenberg ME. 2006. A brain-specific microRNA regulates dendritic spine development. Nature 439:283-289.
83. Segura MF, Belitskaya-Levy I, Rose AE, Zakrzewski J, Gaziel A, Hanniford D, Darvishian F, Berman RS, Shapiro RL, Pavlick AC, Osman I, Hernando E. 2010. Melanoma microRNA signature predicts post-recurrence survival. Clin Cancer Res 16:1577-1586.
84. Sempere LF, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E, Ambros V. 2004. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol 5 R13.
85. Stanczyk J, Pedrioli DM, Brentano F, Sanchez-Pernaute O, Kolling C, Gay RE, Detmar M, Gay S, Kyburz D. 2008. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis and rheumatism 58:1001-1009.
86. Sun E, Shi Y. 2015. MicroRNAs: Small molecules with big roles in neurodevelopment and diseases. Exp Neurol 268:46-53.
87. Szafranska AE, Davison TS, Shingara J, Doleshal M, Riggenbach JA, Morrison CD, Jewell S, Labourier E. 2008. Accurate molecular characterization of formalin-fixed, paraffin-embedded tissues by microRNA expression profiling. J Mol Diagn 10:415-423.
88. Taylor DD, Gercel-Taylor C. 2008. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 110:13-21.
89. Tetzlaff MT, Liu A, Xu XW, Master SR, Baldwin DA, Tobias JW, Livolsi VA, Baloch ZW. 2007. Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues. Endocr Pathol 18:163-173.
90. Thery C, Zitvogel L, Amigorena S. 2002. Exosomes: Composition, biogenesis and function. Nat Rev Immunol 2:569-579.
91. Thomson JM, Parker J, Perou CM, Hammond SM. 2004. A custom microarray platform for analysis of microRNA gene expression. Nat Methods 1:47-53.
92. Thum. 2007. MicroRNAs in the human heart: A clue to fetal gene reprogramming in heart failure (vol 116, pg 258, 2007). Circulation 116:E135-E135.
93. Trionfini P, Benigni A, Remuzzi G. 2015. MicroRNAs in kidney physiology and disease. Nat Rev Nephrol 11:23-33.
94. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. 2007. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654-U672.
95. Valoczi A, Hornyik C, Varga N, Burgyan J, Kauppinen S, Havelda Z. 2004. Sensitive and specific detection of microRNAs by northern blot analysis using LNA-modified oligonucleotide probes. Nucleic Acids Res 32 e175.
96. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, Richardson JA, Olson EN. 2006a. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 103:18255-18260.
97. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, Richardson JA, Olson EN. 2006b. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 103:18255-18260.
98. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103:2257-2261.
99. Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J, Qin YW, Jing Q. 2010. Circulating microRNA: A novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 31:659-666.
100. Wang J, Chen JY, Chang P, LeBlanc A, Li DH, Abbruzzesse JL, Frazier ML, Killary AM, Sen S. 2009. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev Res 2:807-813.
101. Wang J, Paris PL, Chen JY, Ngo V, Yao H, Frazier ML, Killary AM, Liu CG, Liang H, Mathy C, Bondada S, Kirkwood K, Sen S. 2015. Next generation sequencing of pancreatic cyst fluid microRNAs from low grade-benign and high grade-invasive lesions. Cancer Lett 356:404-409.
102. Wang J, Raimondo M, Guha S, Chen JY, Diao LX, Dong XQ, Wallace MB, Killary AM, Frazier ML, Woodward TA, Wang J, Sen S. 2014a. Circulating microRNAs in pancreatic juice as candidate biomarkers of pancreatic cancer. J Cancer 5:696-705.
103. Wang J, Sen S. 2011. MicroRNA functional network in pancreatic cancer: From biology to biomarkers of disease. J Biosciences 36:481-491.
104. Wang J, Zhang KY, Liu SM, Sen S. 2014b. Tumor-associated circulating MicroRNAs as biomarkers of cancer. Molecules 19:1912-1938.
105. Wang WX, Rajeev BW, Stromberg AJ, Ren N, Tang GL, Huang QW, Rigoutsos I, Nelson PT. 2008. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 28:1213-1223.
106. Welch C, Chen Y, Stallings RL. 2007. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 26:5017-5022.
107. Witwer KW 2015. Circulating microRNA biomarker studies: Pitfalls and potential solutions. Clin Chem 61:56-63.
108. Xing LX, Todd NW, Yu L, Fang HB, Jiang F. 2010. Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers. Modern Pathol 23:1157-1164.
109. Xiong YJ, Fang JH, Yun JP, Yang J, Zhang Y, Jia WH, Zhuang SM. 2010. Effects of MicroRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology 51:836-845.
110. Yan Z, Wang J, Wang C, Jiao Y, Qi W, Che S. 2014. MiR-96/HBP1/Wnt/beta-catenin regulatory circuitry promotes glioma growth. FEBS lett 588:3038-3046.
111. Yang Z, Chen H, Si H, Li X, Ding X, Sheng Q, Chen P, Zhang H. 2014. Serum miR-23a, a potential biomarker for diagnosis of pre-diabetes and type 2 diabetes. Acta Diabetol 51:823-831.
112. Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S, Cheng CL, Yu CJ, Lee YC, Chen HS, Su TJ, Chiang CC, Li HN, Hong QS, Su HY, Chen CC, Chen WJ, Liu CC, Chan WK, Chen WJ, Li KC, Chen JJ, Yang PC. 2008. MicroRNA signature predicts survival and relapse in lung cancer. Cancer cell 13:48-57.
113. Yu SN, Lu ZH, Liu CZ, Meng YX, Ma YH, Zhao WG, Liu JP, Yu J, Chen J. 2010. MiRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer. Cancer Res 70:6015-6025.
114. Zampetaki A, Mayr M. 2012. MicroRNAs in vascular and metabolic disease. Circ Res 110:508-522.
115. Zhang GL, Li YX, Zheng SQ, Liu M, Li X, Tang H. 2010a. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210. Antivir Res 88:169-175.
116. Zhang J, Li S, Li L, Li M, Guo C, Yao J, Mi S. 2015. Exosome and exosomal microRNA: Trafficking, sorting, and function. Genomics Proteomics Bioinformatics 13:17-24.
117. Zhang Y, Jia Y, Zheng RY, Guo YJ, Wang Y, Guo H, Fei MY, Sun SH. 2010b. Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem 56:1830-1838.
118. Zhao C, Dong J, Jiang T, Shi Z, Yu B, Zhu Y, Chen D, Xu J, Huo R, Dai J, Xia Y, Pan S, Hu Z, Sha J. 2011. Early second-trimester serum miRNA profiling predicts gestational diabetes mellitus. PloS ONE 6:e23925.
119. Zhao C, Sun G, Li S, Shi Y. 2009. A feedback regulatory loop involving microRNA-9 and nuclear receptor TLX in neural stem cell fate determination. Nat Struct Mol Biol 16:365-371.